Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
Kerwin, Edward M, Tosiello, Robert, Price, Barry, Sanjar, Shahin, Goodin, ThomasVolume:
Volume 13
Language:
english
Journal:
International Journal of Chronic Obstructive Pulmonary Disease
DOI:
10.2147/COPD.S172408
Date:
September, 2018
File:
PDF, 2.98 MB
english, 2018